FPN || Neurology

FDA: No changes needed in management of ezogabine’s eye and skin effects

Posted on: 16/06/2015 - 18:57

Pigment changes in the retina reported in some patients treated with the antiseizure drug ezogabine do not appear to affect vision, and can be “adequately managed” by following recommendations in the...

Field of Interest: Dermatology

Type: News Item

SAEM: High-risk subtypes of delirium are easily missed

Posted on: 19/05/2015 - 21:39

SAN DIEGO – More than 10% of geriatric patients presenting to emergency departments have signs of delirium, but not all delirium in the ED is equal, based on two presentations at the annual...

Field of Interest: Geriatrics

Type: News Item

Androgen deprivation linked to cognitive impairment

Posted on: 11/05/2015 - 21:00

Men treated with androgen-deprivation therapy for advanced prostate cancer appear to be at risk for cognitive decline within 6 months of starting ther... More »

Field of Interest: Oncology

Type: News Item

Oil- and nut-supplemented Mediterranean diet improves elderly cognition

Posted on: 11/05/2015 - 16:00

A Mediterranean diet supplemented by nuts or olive oil was associated with improved cognitive function in people aged 55-80 years, according to Cinta ... More »

Field of Interest: Geriatrics

Type: News Item

Celiac disease more than doubles neuropathy risk

Posted on: 11/05/2015 - 16:00

Individuals with biopsy-confirmed celiac disease have more than double the risk of receiving a diagnosis of neuropathy when compared with the general ... More »

Field of Interest: Gastroentero...

Type: News Item

Alzheimer’s drug improves cognitive function after RT for brain tumors

Posted on: 20/04/2015 - 21:00

Adult brain tumor survivors taking donepezil, a drug approved for the treatment of Alzheimer’s disease, showed significant improvements in the cogni... More »

Field of Interest: Oncology

Type: News Item

Memantine plus cholinesterase inhibitor improves behavioral symptoms in Alzheimer’s

Posted on: 16/04/2015 - 20:37

NEW ORLEANS – The combination of memantine and a cholinesterase inhibitor improved behavioral symptoms in patients with moderate-severe Alzheimer’... More »

Field of Interest: Geriatrics

Type: News Item

Blocking breakdown of arginine may prevent AD

Posted on: 15/04/2015 - 17:55

Certain immune cells that normally protect the brain abnormally consume the nutrient arginine in Alzheimer’s disease (AD) patients, suggests a study... More »

Field of Interest: Geriatrics

Type: News Item

Behavioral symptoms in dementia need a global touch

Posted on: 14/04/2015 - 13:26

NEW ORLEANS–An individualized, step-by-step plan is the best way to treat psychiatric and behavioral problems that might arise in patients with deme... More »

Field of Interest: Geriatrics

Type: News Item

Cerebrospinal fluid marker predicts brain atrophy

Posted on: 13/04/2015 - 16:00

Baseline levels of visinin-like protein 1 in the cerebrospinal fluid were significant predictors of whole brain and regional brain atrophy, based on d... More »

Field of Interest: Geriatrics

Type: News Item

FDA: No changes needed in management of ezogabine’s eye and skin effects

SAEM: High-risk subtypes of delirium are easily missed

Androgen deprivation linked to cognitive impairment

Oil- and nut-supplemented Mediterranean diet improves elderly cognition

Celiac disease more than doubles neuropathy risk

Alzheimer’s drug improves cognitive function after RT for brain tumors

Memantine plus cholinesterase inhibitor improves behavioral symptoms in Alzheimer’s

Blocking breakdown of arginine may prevent AD

Behavioral symptoms in dementia need a global touch

Cerebrospinal fluid marker predicts brain atrophy

Newsletters

Latest Newsletters

You are here

FPN || Neurology

Newsletters

Latest Newsletters